XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended 9 Months Ended 3 Months Ended
Sep. 30, 2012
Successor [Member]
Sep. 30, 2013
Successor [Member]
Dec. 31, 2012
Successor [Member]
Mar. 19, 2012
Predecessor [Member]
Cash flows from operating activities:        
Net (loss) income $ (2,402) $ (7,178) $ (12,353) $ (3,433)
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities before reorganization activities:        
Amortization of bond premium or discount 1,263 1,715   523
Net realized (gain) loss on sale of investments (2,617) 754   (176)
Unrealized (gain) loss on trading securities 594 4,022   (1,049)
Equity-based compensation expense   301 143  
Changes in assets and liabilities:        
Accrued investment income 674 249   309
Other assets 1,569 349   (597)
Change in cash held in trust (68,449) 4,716   7,209
Change in restricted cash (2,273) 25,054    
Losses and loss adjustment reserves (10,321) (24,954)   (1,109)
Losses payable (4,753) 141   1,662
Unearned premiums (96) 1,281   (47)
Accrued ceding commission expense (341) (32)   137
Accrued interest on notes payable 1,452 (369)    
Loss contract fair market value reserve (10,696) (987)    
Other liabilities (3,004) (63)   414
Total Adjustments (96,998) 12,177   7,276
Net cash provided by (used in) operating activities (99,400) 4,999   3,843
Cash flows from investing activities:        
Purchase of investments (145,698) (297,475)   (38,506)
Proceeds from sales and maturities of investments 174,381 318,153   34,035
Net cash provided by (used in) investing activities 28,683 20,678   (4,471)
Cash flows from financing activities:        
Cash from reorganization activities       75,000
Notes payable - principal repayments   (36,294)    
Notes payable - principal issued 4,047 2,203    
Net cash provided by (used in) financing activities 4,047 (34,091)   75,000
Increase (decrease) in cash and cash equivalents (66,670) (8,414)   74,372
Cash and cash equivalents, beginning of period 82,014 16,761 82,014 7,642
Cash and cash equivalents, end of period 15,344 8,347 16,761 82,014
Cash paid during the period:        
Interest 3,668 9,706    
Supplementary disclosure of non-cash investing and financing activities:        
Notes payable issued in lieu of cash interest payments $ 4,047 $ 2,203